시장보고서

상품코드

1812491

세계의 항진균제 시장 : 약제 유형별, 적응증별, 제형별, 유통 채널별, 지역별

Anti Fungal Drugs Market, By Drug Type, By Indication, By Dosage Form, By Distribution Channel, By Geography

발행일: 2025년 08월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 항진균제 시장은 2025년 150억 달러로 추정되며, 2023년까지 190억 8,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 연평균 성장률(CAGR)은 3.5%로 성장할 전망입니다.

분석 범위		분석 상세
기준연도	2024년	시장 규모(2025년)	150억 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측기간 CAGR(2025-2032년)	3.50%	예측 금액(2032년)	190억 8,000만 달러

항진균제는 개인의 곰팡이 감염을 치료하는 데 사용됩니다. 곰팡이성 손발톱 감염, 백선과 같은 일반적인 곰팡이 감염은 일반적으로 신체의 외부 표면에서 발생하지만, 특정 침습성 곰팡이 감염은 신체 조직 또는 폐 및 뇌와 같은 내장에서 발생합니다. 진균 감염은 보통 HIV/AIDS 환자 등 면역력이 약한 사람에게 많이 보입니다. 또한 화학요법을 받은 환자는 침습성 곰팡이증에 걸리기 쉽습니다. 항진균제는 곰팡이 세포를 죽이거나 증식을 억제하여 곰팡이 감염에 작용합니다. 항진균제는 외용 항진균제, 경구 항진균제, 정맥내 항진균제, 질내 항진균 페서리로 크게 나뉩니다.

시장 역학

시장의 주요 기업은 시장에서의 존재감을 높이기 위해 제휴 및 계약 등의 성장 전략에 주력하고 있습니다. 예를 들어, 2017년 6월 바이오 의약품 회사인 Basilea Pharmaceutica Ltd.는 Pfizer, Inc. 및 Avir Pharma, Inc.와 Beasilea의 항진균 치료제 판매권 계약을 체결했습니다. Pfizer는 러시아, 이스라엘, 유럽(북유럽 제외), 튀르키예 등의 지역에서 생명을 위협하는 침습성 곰팡이 감염증의 치료제을 제조 및 판매합니다.

마찬가지로 시장의 주요 기업은 제품 포트폴리오를 확대하기 위해 R&D 등 다양한 사업 전략에 주력하고 있습니다. 의약품 개발 증가는 이 시장의 성장을 가속할 것으로 예측됩니다. 예를 들어, 2019년 1월, 바이오테크놀러지 기업인 SCYNEXIS, Inc.는 진행중인 FURI 시험의 첫 번째 중간 효율 분석에서 좋은 중간 결과를 발표했습니다. 이 새로운 치료제의 개발은 항진균 치료를 적응시킵니다.

이 보고서의 주요 특징

본 보고서는 세계 항진균제 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모·CAGR을 제공합니다.
또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품의 출시와 승인, 시장 동향, 지역별 전망, 주요기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
세계 항진균제 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개 변수를 기반으로 게시됩니다.
이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
'세계 항진균제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
이해관계자는 세계 항진균제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 15 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	3.50%	2032 Value Projection:	USD 19.08 Bn

Antifungal drugs are used to treat fungal infections in individuals. Common fungal infections such as fungal nail infection, and ringworm etc. usually occur on the external surface of the body, while certain invasive fungal infections occur inside the body tissues or inside internal organs such as lungs and brain. Fungal infection is usually associated with individuals having weak immune system, such as people suffering from HIV/AIDS. Moreover, patients undergoing chemotherapy are susceptible to invasive fungal infections. Antifungal drugs act against the fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.

Market Dynamics

Major players in the market are focused on growth strategies such as collaborations and agreements in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into an agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution rights of Beasilea's antifungal treatments. Pfizer will manufacture and distribute drugs for the treatment of life-threatening invasive mold infections in regions like Russia, Israel, Europe (excluding Nordics), and Turkey.

Similarly, key players in the market are focused on various business strategies such as research and development in order to expand their product portfolio. Increasing drug development is expected to drive growth of this market. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from their first interim efficiency analysis of an ongoing FURI study. The development of this novel treatment is indicated for antifungal treatment.

Key features of the study

This report provides an in-depth analysis of global antifungal drugs market, provides market size (USD Bn), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global antifungal drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global antifungal drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antifungal drugs market.

Market Segmentation

By Drug Type
- Echinocandins
- Polyenes
- Allylamines
- Azoles
- Others
By Application
- Neurosurgery
- Plastic Surgery
- Cardiovascular Surgery
- Obstetrics & Gynecology
- Others
By Indication
- Aspergillosis
- Dermatophytosis
- Candidiasis
- Mucormycosis
- Others
By Dosage Form
- Powders
- Ointments
- Injections
- Tablets
- Others
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline Plc
- Bayer AG
- Abbott Laboratories
- Merck & Co., Inc.
- Glenmark Pharmaceuticals Limited
- Enzon Pharmaceuticals, Inc.
- Pfizer Inc.
- Gilead Sciences, Inc.
- Sanofi S.A.
- Astellas Pharma, Inc.
- Alembic Pharmaceuticals Limited
- SCYNEXIS, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Anti Fungal Drugs Market, By Drug Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Echinocandins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Polyenes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Allylamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Azoles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends

5. Global Anti Fungal Drugs Market, By Indication, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Aspergillosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Dermatophytosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Mucormycosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends

6. Global Anti Fungal Drugs Market, By Dosage Form, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Powders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

7. Global Anti Fungal Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

8. Global Anti Fungal Drugs Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GlaxoSmithKline Plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bayer AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott Laboratories
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Glenmark Pharmaceuticals Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Enzon Pharmaceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Gilead Sciences, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sanofi S.A.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Astellas Pharma, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Alembic Pharmaceuticals Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- SCYNEXIS, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

10. Section

References
Research Methodology
About us and Sales Contact

세계의 항진균제 시장 : 약제 유형별, 적응증별, 제형별, 유통 채널별, 지역별

Anti Fungal Drugs Market, By Drug Type, By Indication, By Dosage Form, By Distribution Channel, By Geography

시장 역학

이 보고서의 주요 특징

목차

제1장 분석 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 항진균제 시장, 약제유형별(2020-2032년)

제5장 세계의 항진균제 시장 : 적응증별(2020-2032년)

제6장 세계의 항진균제 시장 : 제형별(2020-2032년)

제7장 세계의 항진균제 시장 : 유통 채널별(2020-2032년)

제8장 세계의 항진균제 시장 : 지역별(2020-2032년)

제9장 경쟁 구도

제10장 섹션